Griseofulvin, Ultramicrosize
Generic Name: griseofulvin, ultramicrosize
Manufactured by BAUSCH. Dosage form: TABLET. Route: ORAL. Active ingredients: GRISEOFULVIN, ULTRAMICROSIZE (250MG). Application: NDA050475.
Overview
Manufactured by BAUSCH. Dosage form: TABLET. Route: ORAL. Active ingredients: GRISEOFULVIN, ULTRAMICROSIZE (250MG). Application: NDA050475.
Dosage
Available as tablet for oral use.
Related Medications
Strychnos Ignatii Whole, Ferrosoferric Phosphate, And Sepia Officinalis Juice
strychnos ignatii whole, ferrosoferric phosphate, and sepia officinalis juice
Regulates energy flow in the bladder meridian.
Soybean Oil
soybean oil
Lipid Emulsion [EPC]
11 DESCRIPTION Nutrilipid 20% is a homogenous white and milky sterile, nonpyrogenic lipid emulsion for intravenous administration. Each 100 mL of Nutrilipid 20% contains: Soybean Oil 20 g; Egg Yolk Phospholipid 1.2 g; Glycerin USP (glycerol) 2.5 g; Sodium Oleate 0.03 g; Water for Injection USP qs. pH adjusted with Sodium Hydroxide NF. pH: 6.8 (6.0-8.9); Osmolality: 390 mOsmol/kg (actual).
Denosumab-desu
denosumab-desu
Manufactured by ACCORD BIOPHARMA INC.. Dosage form: INJECTABLE. Route: SUBCUTANEOUS. Active ingredients: denosumab-desu (120MG/1.7ML). Application: BLA761424.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.